Camber Pharmaceuticals launches generic Onfi
Camber Pharmaceuticals is introducing clobazam tablets.
Clobazam tablets are the generic version of Lundbeck's Onfi.
The product, which is used to treat seizures, is available in 10 mg and 20 mg 100-count bottles, the company said.
Clobazam tablets had a market value of about $594 million for the 12 months ended August 2018, according to IQVIA data.
Clobazam tablets are the generic version of Lundbeck's Onfi.
The product, which is used to treat seizures, is available in 10 mg and 20 mg 100-count bottles, the company said.
Clobazam tablets had a market value of about $594 million for the 12 months ended August 2018, according to IQVIA data.